Patents Assigned to TEXAS MEDICAL CENTER
-
Patent number: 12040083Abstract: Disclosed herein are methods for intelligently populating medical compliance forms (MCFs) with at least patient data to meet compliance requirements (e.g., meeting patient data compliance requirements such as HIPAA requirements, as well as compliance requirements concerning patient forms). In particular, methods involve training and deploying machine learning models that can appropriately analyze a wide array of MCFs with varying formats. Advantages of the methods disclosed herein are three-fold: 1) reducing the amount of time and resources that a healthcare provider needs to commit to satisfying compliance requirements and 2) improving patient outcome by more intelligently incorporating data in medical compliance forms, and 3) ensuring meeting of compliance requirements (e.g., HIPAA compliance requirements).Type: GrantFiled: July 28, 2023Date of Patent: July 16, 2024Assignee: Texas Medical CenterInventors: Omar Mohtar, Vibhav Jha
-
Patent number: 11925731Abstract: Provided are methods, devices and compositions for reducing and/or inhibiting postsurgical tissue adhesion using a hydrogel film disposed onto a target tissue, thereby providing an adhesion barrier that remains over said target tissue for a prescribed period of time. In some embodiments, the hydrogel film is formed by the gelation of a pre-gel mixture applied onto the target tissue as a plurality of particles having an average maximum dimension, such as diameter, of at most about 500 ?m. In some embodiments, the hydrogel film has a minimum storage modulus of 100 Pa. In some embodiments, the pre-gel mixture comprises an ECM digest having a collagen to carbohydrate ratio (by mass) of at least 70:1.Type: GrantFiled: August 26, 2022Date of Patent: March 12, 2024Assignee: TEXAS MEDICAL CENTERInventors: Timothy J. Keane, Jr., Peter Alexander Smith, Stephen G. Ramon
-
Patent number: 11179097Abstract: Tactile sensing devices, systems, and methods to image a target tissue location are disclosed. When force is applied to the tactile sensing device, voltage data is detected and visualized on a screen, indicating the target tissue location.Type: GrantFiled: March 21, 2018Date of Patent: November 23, 2021Assignee: TEXAS MEDICAL CENTERInventors: Nicole C. Moskowitz, Jessica Traver, Xavier Garcia-Rojas, Yashar Ganjeh
-
Publication number: 20200360670Abstract: Provided herein are catheter devices, systems, and methods to ablate a tissue location. The devises, systems, and methods disclosed herein comprise catheters comprising a fenestrated nozzle, ablation balloons, and an ablation medium that is directed at a tissue location.Type: ApplicationFiled: August 7, 2020Publication date: November 19, 2020Applicant: Texas Medical CenterInventors: Benjamin Morgan LEGUM, Shadi SHARIATNIA, Matthew Aria NOJOOMI, Kovi Ethan BESSOFF
-
Patent number: 10004450Abstract: Tactile sensing devices, systems, and methods to image a target tissue location are disclosed. When force is applied to the tactile sensing device, voltage data is detected and visualized on a screen, indicating the target tissue location.Type: GrantFiled: May 2, 2017Date of Patent: June 26, 2018Assignee: TEXAS MEDICAL CENTERInventors: Nicole C. Moskowitz, Jessica Traver, Xavier Garcia-Rojas, Yashar Ganjeh
-
Publication number: 20030157717Abstract: Linear double-stranded DNA fragments containing a promoter, a nucleotide sequence, such as a transgene, preferably non-viral, and a 3′ untranslated region, are delivered to tissue of an animal by direct injection accompanied by electroporation. Long-term expression of the transgene results in prolonged availability of proteins, hormones, or enzymes that may be deficient in the mammal. In addition, the linear fragments increase the safety of the vectors for mammalian gene therapy by avoiding deleterious side effects.Type: ApplicationFiled: September 6, 2002Publication date: August 21, 2003Applicant: Baylor College of Medicine Texas Medical CenterInventor: Ruxandra Draghia-Akli
-
Patent number: 5571697Abstract: The subject invention provides for the production of lactoferrins and lactoferrin polypeptide fragments using the host cells Aspergillus in combination with novel plasmid constructs. More specifically, the subject invention provides novel vector constructs capable of producing lactoferrins and lactoferrin polypeptide fragments in Aspergillus host cells. More particularly, the subject invention provides for novel plasmid constructs suitable for use with Aspergillus and especially Aspergillus awamori, niger and oryzae host cells, which enables them to produce large amounts of recombinant lactoferrins and lactoferrin polypeptide fragments.Type: GrantFiled: November 2, 1994Date of Patent: November 5, 1996Assignee: Baylor College of Medicine Texas Medical CenterInventors: Orla M. Conneely, Denis R. Headon, Bert W. O'Malley
-
Patent number: 5524445Abstract: A refrigerant leak detection apparatus and method for testing for leaking frigerant within a heat exchanging fluid, particularly for testing for leaking refrigerant in a chiller system comprising heat exchangers.Type: GrantFiled: March 31, 1995Date of Patent: June 11, 1996Assignee: Texas Medical Center Central Heating and Cooling Cooperative AssociationInventors: Gordon R. Morrow, Coy M. White
-
Patent number: 5351500Abstract: A refrigerant leak detection apparatus and method for testing for leaking frigerant within a heat exchanging fluid, particularly for testing for leaking refrigerant in a chiller system comprising heat exchangers.Type: GrantFiled: December 3, 1993Date of Patent: October 4, 1994Assignee: Texas Medical Center Central Heating and Cooling Cooperative AssociationInventor: Gordon R. Morrow